pharmacological cardioversion
Showing 1 - 25 of 3,477
Atrial Fibrillation Paroxysmal Trial in Moscow (Pharmacological cardioversion with Amiodarone, Pharmacological cardioversion
Recruiting
- Atrial Fibrillation Paroxysmal
- Pharmacological cardioversion with Amiodarone
- Pharmacological cardioversion with Refralon
-
Moscow, Russian FederationFederal State Budgetary Institution NATIONAL MEDICAL RESEARCH CE
Jul 5, 2022
Atrial Fibrillation Trial in Warsaw (Antazoline, Propafenone)
Recruiting
- Atrial Fibrillation
-
Warsaw, PolandPostgraduate Medical School
Feb 12, 2023
Atrium; Fibrillation, Atrium; Flutter Trial in Moscow (Pharmacological cardioversion with Refralon)
Recruiting
- Atrium; Fibrillation
- Atrium; Flutter
- Pharmacological cardioversion with Refralon
-
Moscow, Russian FederationFederal State Budgetary Institution NATIONAL MEDICAL RESEARCH CE
Jul 13, 2022
Paroxysmal Atrial Fibrillation Trial in Madrid (Vernakalant, Flecainide)
Recruiting
- Paroxysmal Atrial Fibrillation
-
Madrid, Madrid/Madrid, SpainHospital Clínico Universitario San Carlos
Aug 5, 2022
Atrial Fibrillation Trial in Netherlands (Rate control, Pharmacological or electrical cardioversion)
Recruiting
- Atrial Fibrillation
- Rate control
- Pharmacological or electrical cardioversion
-
Maastricht, Limburg, Netherlands
- +13 more
Dec 2, 2021
Atrial Fibrillation Trial in Netherlands (Pharmacological cardioversion - Flecainide, Electrical cardioversion, Metoprolol)
Completed
- Atrial Fibrillation
- Pharmacological cardioversion - Flecainide
- +5 more
-
Amsterdam, Netherlands
- +14 more
Jan 17, 2020
Refralon®, Concentrate for Solution for Intravenous Injection in
Recruiting
- Paroxysmal Atrial Fibrillation
- +2 more
-
Ufa, Bashkortostan Republic, Russian Federation
- +31 more
Mar 6, 2023
Atrial Fibrillation Trial (Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor, Rhythm control and anticoagulation)
Not yet recruiting
- Atrial Fibrillation
- Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
- Rhythm control and anticoagulation
- (no location specified)
Aug 14, 2023
Stepwise Strategy for Modifying Atrial Fibrillation Substrate
Recruiting
- Atrial Fibrillation
- late gadolinium enhanced magnetic resonance imaging
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Jul 26, 2022
Atrial Fibrillation, Atrial Flutter Trial in Canada (drug-shock vs shock only)
Completed
- Atrial Fibrillation
- Atrial Flutter
- drug-shock vs shock only
-
Calgary, Alberta, Canada
- +9 more
Jul 19, 2019
Atrial Fibrillation Trial in Indianapolis (Ondansetron 8mg, Placebo)
Not yet recruiting
- Atrial Fibrillation
- Ondansetron 8mg
- Placebo
-
Indianapolis, Indiana
- +2 more
Apr 25, 2023
Atrial Fibrillation Trial in Calgary (Amiodarone Hydrochloride, Placebo)
Recruiting
- Atrial Fibrillation
- Amiodarone Hydrochloride
- Placebo
-
Calgary, Alberta, CanadaUniversity of Calgary
Feb 7, 2022
Atrial Fibrillation, Post-cardiac Surgery Trial (Vernakalant, Amiodarone)
Not yet recruiting
- Atrial Fibrillation
- Post-cardiac Surgery
- (no location specified)
May 16, 2022
Atrial Fibrillation Trial in Hamburg (Re-PVI only, Re-PVI + substrate ablation)
Recruiting
- Atrial Fibrillation
- Re-PVI only
- Re-PVI + substrate ablation
-
Hamburg, GermanyAsklepios Klinik St. Georg
Aug 9, 2022
Atrial Fibrillation Trial in Madrid (Line Set Strategy, Conventional strategy)
Recruiting
- Atrial Fibrillation
- Line Set Strategy
- Conventional strategy
-
Madrid, SpainHospital Universitario 12 de Octubre
Apr 24, 2023
Paroxysmal Atrial Fibrillation Trial in Worldwide (Boston Scientific Cardiac Cryoablation System)
Active, not recruiting
- Paroxysmal Atrial Fibrillation
- Boston Scientific Cardiac Cryoablation System
-
Phoenix, Arizona
- +43 more
Aug 23, 2022
Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As
Recruiting
- Atrial Fibrillation
- +2 more
- As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
-
Burlington, VermontUniversity of Vermont Medical Center
Feb 28, 2023
Heart Valve Incompetence, Atrial Fibrillation, Persistent Trial in Milan, MIlan (Echocardiography, Proteomic analyses)
Recruiting
- Heart Valve Incompetence
- Atrial Fibrillation, Persistent
- Echocardiography
- Proteomic analyses
-
Milan, Select A State, Italy
- +1 more
Feb 28, 2023
COVID-19 Pneumonia, Atrial Fibrillation Trial in Tanta (Dexmedetomidine sedation)
Not yet recruiting
- COVID-19 Pneumonia
- Atrial Fibrillation
- Dexmedetomidine sedation
-
Tanta, ELgharbiaa, EgyptTanta University Hospitals
Dec 22, 2021
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Out of Range Hypertension Trial in Netherlands, Spain
Completed
- Paroxysmal Atrial Fibrillation
- +3 more
- procedure
-
Zwolle, Overijssel, Netherlands
- +7 more
Jul 8, 2022
Atrial Fibrillation Trial in Buffalo (Magnesium Sulfate, Placebo)
Completed
- Atrial Fibrillation
- Magnesium Sulfate
- Placebo
-
Buffalo, New YorkState University of New York at Buffalo
Sep 29, 2020
Atrial Fibrillation Prior and Post Elective Cardioversion
Not yet recruiting
- Atrial Fibrillation
- ECG monitoring prior and after cardioversion
- (no location specified)
Jun 29, 2023
Morbidity of Cardiac Rhythm Disorders in Patients Assisted by
Not yet recruiting
- Cardiac Rhythm Disorder
- Follow up by phone call
- (no location specified)
Mar 27, 2023